Edwin Enrique Martínez Leo

Edwin Enrique Martínez Leo

Auto-generated profile, based on publicly available information

Edwin Enrique Martínez Leo

Research Department, University Latino, Merida, Mexico; School of Medicine, Autonomous University of Yucatan, Merida, Mexico

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Nutrition
Verified
Journal Article
Closed access
ELEdwin E. Martínez Leo
Edwin E. Martínez Leo
APAbigail Meza Peñafiel
Abigail Meza Peñafiel
VHVictor M Hernandez-Escalante
Victor M Hernandez-Escalante
ZAZulema M. Cabrera Araujo
Zulema M. Cabrera Araujo

22 June 2021 in Food & Function
Verified
Journal Article
Closed access
PDF file
EDEdwin A. Torres Dominguez
Edwin A. Torres Dominguez
APAbigail Meza Peñafiel
Abigail Meza Peñafiel
APArturo Gómez Pedraza
Arturo Gómez Pedraza
ELEdwin E. Martínez Leo
Edwin E. Martínez Leo
Diabetes mellitus is a complex and multifactorial disease with a global prevalence that exceeds 425 million people. Type 2 diabetes mellitus (T2DM) is characterized by a state of insulin resistance, which leads to metabolic alterations that aggravate the state of health of people. Vitamin D deficiency appears to play an important role in the triggering mechanisms of insulin resistance. In this review, an analysis is made of the biochemical mechanisms associated with the insulin-mimetic effect of vitamin D, its supplementation being a possible nutritional strategy for the T2DM treatment. The current scientific evidence is extensive regarding the dose of vitamin D used for an insulin-mimetic effect. However, clinical trials and systematic reviews show statistical differences on glucose, insulin, and glycated hemoglobin levels of patients with T2DM, associated with activation mechanisms of transcription factors related to genes of the glucide metabolism and the insulin receptor, and the regulation of intracellular Ca2+ insulin concentrations. Likewise, an indirect mechanism associated with antioxidant and anti-inflammatory effects has been shown that also leads to sensitivity to the insulin receptor. The use of a specific dose of vitamin D could be an effective alternative in the T2DM treatment, which would reduce the risk of complications derived from hyperglycemia.

25 September 2024
Verified
Book Chapter
Open access
PDF file
ELEdwin Enrique Martínez Leo
Edwin Enrique Martínez Leo
APAbigail Meza Peñafiel
Abigail Meza Peñafiel
DODanna Paola Mena Ortega
Danna Paola Mena Ortega
Currently, 1 in 3 people have an adiposity-based chronic disease (ABCD), a situation that in recent decades has been on the rise. The systemic oxidative stress characteristic of ABCD is a complex and systemic state that derives from the deregulation of the musculoskeletal system and the loss of cellular antioxidant capacity. In the present review, we analyze the mechanisms of antioxidant bioactive compounds that, in clinical evidence, have shown a potential effect on the reduction of oxidative stress in people with ABCD. Research presented in this review was identified through searches of PubMed/Medline, EMBASE and the Cochrane Library databases. Observational studies report that people with ABCD have lower serum concentrations of antioxidants such as vitamins C, E and coenzyme Q10. Scientific evidence affirms that the use of antioxidants in the nutritional therapy of people with ABCD results in a decrease in prooxidative markers. In clinical practice, various factors such as diet, pharmacotherapy, stress levels and disease progression could reduce the efficacy of antioxidant compounds in the nutritional treatment of ABCD. The appropriate dosage of bioactive compounds with antioxidant effects results in a potential ally in the metabolic control of people with ABCD.